Drug Database
IM

immunoglobulin G

✓ Approved

Quimbiotec · 多克隆抗体 · 多克隆抗体

什么是 immunoglobulin G?

immunoglobulin G 是一种多克隆抗体,由Quimbiotec研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

公司Quimbiotec
药物类别多克隆抗体, 抗体
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

immunoglobulin G 针对 4 个适应症,涉及 4 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersGuillain-Barre syndrome✓ Approved
Skin and subcutaneous tissue disordersPurpura✓ Approved
Immune system disordersImmunodeficiency✓ Approved
Infections and infestationsBorna virus infection✓ Approved

相关研究文献

PubMedHaematologica2026-11-19

Comment on: "Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab".

Rago Angela A, Zomparelli Marco M, Di Toritto Tommaso Caravita TC

PMID 43053702
阅读全文 →
PubMedBMC public health2026-11-19

Post-pandemic SARS-CoV-2 seroprevalence and population immunity in Conakry, Guinea, 2024.

Kadio Kadio Jean Jacques Olivier KJJO, Diallo Haby H, Gnimadi Thibaut Armel Chérif TAC, Soumah Abdoul Karim AK et al.

Since May 2023, COVID-19 is no longer a Public Health Emergency of International Concern. However, it remains an infection that requires monitoring, especially in the post-emergency context where testing and preventative measures have been abandoned by the population. The objective of this study was therefore to measure the seroprevalence of antibodies against SARS-CoV-2 in Conakry in the post-health emergency period and to identify the associated factors. In January 2024, we conducted a population-based, age-stratified seroprevalence survey in Conakry. We collected demographic and epidemiological information, as well as dried blood spot samples, and tested them for immunoglobulin G (IgG) antibodies to SARS-CoV-2 recombinant nucleocapsid and spike proteins using Luminex technology. Overall, 1018 individuals with a median age of 18 years (IQR: 10-37 years) from 180 households participated in the survey. The overall weighted and age-standardized SARS-CoV-2 IgG seroprevalence against spike and nucleocapsid proteins was 88.9% (95% CI: 80.8-93.9). People with secondary education (AOR = 4.10, 95% CI: 1.46-11.51) and those who had been vaccinated (AOR = 2.53, 95% CI: 1.26-5.10) were significantly more likely to have SARS-CoV-2 antibodies. High SARS-CoV-2 seroprevalence in Conakry indicates widespread community exposure through infection and/or vaccination. Secondary education and vaccination were associated with antibody positivity. Despite strong population immunity, continued surveillance, improved vaccine access, and strengthened public health communication remain essential to address ongoing viral circulation and potential waning immunity in Guinea.

PMID 43052926
阅读全文 →
PubMedJournal of pediatric gastroenterology and nutrition2026-11-19

Atypical inflammatory bowel disease and multi-system inflammation expand the phenotype of inhibitor of nuclear factor kappa B kinase subunit beta gain-of-function variants.

Ashton James J JJ, Selby Mercedes M, Green Zachary Z, Win Lynn K LK et al.

Gain-of-function (GoF) variants in the inhibitor of nuclear factor kappa-B kinase subunit beta (IKK2) protein, encoded by inhibitor of nuclear factor kappa B kinase subunit beta (IKBKB), have previously been reported to cause autoinflammation with a progressive immunodeficiency. Genetic defects have not previously been described in inflammatory bowel disease (IBD), although disruption of highly interacting proteins, such as IKBKG and RELA, are known causes of monogenic IBD. Using whole exome sequencing data, we screened a cohort of over 1250 adult and paediatric onset patients with IBD for deleterious variants (minor allele frequency < 0.0005, Combined Annotation Dependent Depletion [CADD] > 15) in IKBKB. We retrieved in-depth phenotypic data and performed peripheral blood mononuclear cell CD25/CD70 stimulation validation in patients with apparent IKBKB GoF variants. We identified 11 patients with potentially pathogenic variants. Correlation with clinical and immunophenotypic data prioritised a rare, potential gain-of-function, variant in a patient and his affected parent, c.522T>G, p Asp174Glu. The proband had multi-system inflammation and severe atypical inflammatory bowel disease with rectal stricturing. We demonstrated impaired CD25/CD70 T- and B-cell responses in the patient, characteristic of the IKBKB defect, alongside hallmark immunological manifestations of reduced natural killer and B-cell numbers, and perturbed immunoglobulin titres. Treatment with a selective Janus kinase (JAK1)-inhibitor resulted in rapid clinical and biochemical improvement. This study expands the phenotypic manifestation of IKBKB GoF variants to include IBD and demonstrates a biologically plausible targeted treatment. Further functional work is required to elucidate the precise mechanism of bowel inflammation and identify additional patients.

PMID 43053635
阅读全文 →
PubMedNature communications2026-11-19

Metabolic engineering and deep learning-driven protein engineering for N-Acetylneuraminic acid biosynthesis in Escherichia coli.

Wang Nan-Kai NK, Yue Song S, Chen Jin-Ping JP, Su Chang C et al.

N-Acetylneuraminic acid (NeuAc) is a sialic acid valued in pharmaceuticals and infant nutrition, and microbial synthesis offers a scalable route once the pathway's catalytic bottlenecks are relieved. We combine deep learning with metabolic engineering to build a high-titer NeuAc-producing E.coli strain. Modular pathway engineering reaches 1.25 g L-1 and pinpoints N-acetylglucosamine 2-epimerase (AGE) as the rate-limiting step. We develop DLCatalysis, a deep learning framework that predicts kcat Km-1 directly from protein sequence and substrate, and use it to mine AGEBf that lifts the titer to 6.84 g L-1. DLCatalysis-guided redesign of AGEBf and NeuBNm raises NeuAc to 9.27 g L⁻¹, and identifying and deleting exuT, a previously unannotated NeuAc transporter, blocks product reuptake. In 5-L fed-batch fermentation the optimized strain produces 85.5 g L-1, showing that AI-guided enzyme discovery can resolve the bottlenecks that have limited microbial NeuAc production.

PMID 43052267
阅读全文 →
PubMedClinical pediatrics2026-11-19

Patterns and Factors Associated With Coronary Artery Involvement in Kawasaki Disease: Experience From Southern Tunisia.

Elleuch Amal A, Elleuch Imen I, Ben Halima Asma A, Gargouri Rania R et al.

Kawasaki disease (KD) is a paediatric vasculitis associated with coronary complications. We aimed to describe clinical and echocardiographic characteristics and factors associated with coronary involvement. This retrospective, single-centre study included 70 children over 18 years (2007-2024). Univariate analyses assessed clinical and laboratory associations. The mean age was 55.4 ± 32.8 months; 61.7% were younger than 5 years. Coronary involvement occurred in 32/70 (45.7%), including dilation in 25 (35.7%), wall thickening in 7 (10.0%) and aneurysms in 3 (4.3%). Lesions regressed in 27/32 (84.4%). Significant associations included cheilitis, rash, cervical lymphadenopathy, cough, rhinorrhoea, leucocytosis, lymphocytosis, lower mean corpuscular volume, higher mean corpuscular haemoglobin concentration, thrombocytosis and elevated alanine aminotransferase. These unadjusted associations do not establish independent predictors. Early diagnosis, intravenous immunoglobulin and aspirin remain essential. Systematic echocardiographic assessment, structured follow-up and larger multicentre studies are needed to improve coronary risk stratification and long-term outcomes in children with KD.

PMID 43052696
阅读全文 →
PubMedJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2026-11-19

Corrigendum to "Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic".

PMID 43053620
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多immunoglobulin G